Pitfalls in Reporting Sample Size Calculation Across Randomized Controlled Trials Involving Ivermectin for the treatment of COVID-19

{ 'indexed': {'date-parts': [[2023, 9, 18]], 'date-time': '2023-09-18T04:35:25Z', 'timestamp': 1695011725354}, 'reference-count': 24, 'publisher': 'Ovid Technologies (Wolters Kluwer Health)', 'issue': '5', 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'DOI': '10.1097/mjt.0000000000001441', 'type': 'journal-article', 'created': {'date-parts': [[2021, 8, 13]], 'date-time': '2021-08-13T13:55:18Z', 'timestamp': 1628862918000}, 'page': 'e616-e619', 'source': 'Crossref', 'is-referenced-by-count': 4, 'title': 'Pitfalls in Reporting Sample Size Calculation Across Randomized Controlled Trials Involving ' 'Ivermectin for the treatment of COVID-19', 'prefix': '10.1097', 'volume': '28', 'author': [ { 'given': 'Chia Siang', 'family': 'Kow', 'sequence': 'first', 'affiliation': [ { 'name': 'School of Pharmacy, Monash University Malaysia Bandar Sunway, ' 'Selangor, Malaysia'}, { 'name': 'School of Postgraduate Studies, International Medical ' 'University, Kuala Lumpur, Malaysia'}]}, { 'given': 'Syed S.', 'family': 'Hasan', 'sequence': 'additional', 'affiliation': [ { 'name': 'School of Applied Sciences, University of Huddersfield, ' 'Huddersfield, United Kingdom'}, { 'name': 'School of Biomedical Sciences and Pharmacy University of ' 'Newcastle, Callaghan, Australia'}]}], 'member': '276', 'published-online': {'date-parts': [[2021, 9]]}, 'reference': [ { 'key': 'R1-20230917', 'doi-asserted-by': 'crossref', 'first-page': '533', 'DOI': '10.1016/S1473-3099(20)30120-1', 'article-title': 'An interactive web-based dashboard to track COVID-19 in real time', 'volume': '20', 'author': 'Dong', 'year': '2020', 'journal-title': 'Lancet Infect Dis.'}, { 'key': 'R2-20230917', 'article-title': 'The use of remdesivir for the management of patients with ' 'moderate-to-severe COVID-19: a systematic review', 'author': 'Thiruchelvam', 'year': '2021', 'journal-title': 'Expert Rev Anti Infect Ther.'}, { 'key': 'R3-20230917', 'doi-asserted-by': 'crossref', 'DOI': '10.1080/17476348.2021.1925546', 'article-title': 'Does methylprednisolone reduce the mortality risk in hospitalized ' 'COVID-19 patients? A meta-analysis of randomized control trials', 'author': 'Hasan', 'year': '2021', 'journal-title': 'Expert Rev Respir Med.'}, { 'key': 'R4-20230917', 'doi-asserted-by': 'crossref', 'DOI': '10.1007/s43440-021-00245-z', 'article-title': 'The association between the use of ivermectin and mortality in patients ' 'with COVID-19: a meta-analysis', 'author': 'Kow', 'year': '2021', 'journal-title': 'Pharmacol Rep.'}, { 'key': 'R5-20230917', 'doi-asserted-by': 'crossref', 'first-page': '104787', 'DOI': '10.1016/j.antiviral.2020.104787', 'article-title': 'The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 ' 'in vitro', 'volume': '178', 'author': 'Caly', 'year': '2020', 'journal-title': 'Antivir Res'}, { 'key': 'R6-20230917', 'doi-asserted-by': 'crossref', 'first-page': 'e3001162', 'DOI': '10.1371/journal.pbio.3001162', 'article-title': 'The methodological quality of 176,620 RCTs published between 1966 and ' '2018 reveals a positive trend but also an urgent need for improvement', 'volume': '19', 'author': 'Vinkers', 'year': '2021', 'journal-title': 'PLoS Biol.'}, { 'key': 'R7-20230917', 'doi-asserted-by': 'crossref', 'first-page': '107', 'DOI': '10.1016/j.ijid.2020.09.1470', 'article-title': 'Use of hydroxychloroquine and chloroquine in COVID-19: how good is the ' 'quality of RCTs?', 'volume': '101', 'author': 'Mazhar', 'year': '2020', 'journal-title': 'Int J Infect Dis.'}, { 'key': 'R8-20230917', 'doi-asserted-by': 'crossref', 'first-page': 'S12', 'DOI': '10.1016/j.chest.2020.03.010', 'article-title': 'Sample size estimation in clinical research: from RCTs to observational ' 'studies', 'volume': '158', 'author': 'Wang', 'year': '2020', 'journal-title': 'Chest'}, { 'key': 'R9-20230917', 'doi-asserted-by': 'crossref', 'first-page': 'e434', 'DOI': '10.1097/MJT.0000000000001402', 'article-title': 'Ivermectin for prevention and treatment of COVID-19 infection: a ' 'systematic review, meta-analysis, and trial sequential analysis to ' 'inform clinical guidelines', 'volume': '28', 'author': 'Bryant', 'year': '2021', 'journal-title': 'Am J Ther.'}, { 'key': 'R10-20230917', 'doi-asserted-by': 'crossref', 'first-page': '693', 'DOI': '10.1056/NEJMoa2021436', 'article-title': 'Dexamethasone in hospitalized patients with covid-19', 'volume': '384', 'author': 'Horby', 'year': '2021', 'journal-title': 'N Engl J Med.'}, { 'key': 'R11-20230917', 'doi-asserted-by': 'crossref', 'first-page': '220', 'DOI': '10.1186/s12874-020-01101-z', 'article-title': 'Statistical design of Phase II/III clinical trials for testing ' 'therapeutic interventions in COVID-19 patients', 'volume': '20', 'author': 'Rai', 'year': '2020', 'journal-title': 'BMC Med Res Methodol'}, { 'key': 'R12-20230917', 'doi-asserted-by': 'crossref', 'first-page': '1426', 'DOI': '10.1001/jama.2021.3071', 'article-title': 'Effect of ivermectin on time to resolution of symptoms among adults ' 'with mild COVID-19: a randomized clinical trial', 'volume': '325', 'author': 'López-Medina', 'year': '2021', 'journal-title': 'JAMA'}, { 'key': 'R14-20230917', 'first-page': '10', 'article-title': 'Ivermectin as a potential treatment for mild to moderate COVID-19—a ' 'double blind randomized placebo-controlled trial', 'volume': '2021', 'author': 'Ravikirti', 'year': '2021', 'journal-title': 'medRxiv'}, { 'key': 'R15-20230917', 'doi-asserted-by': 'crossref', 'first-page': '235', 'DOI': '10.1080/20477724.2021.1890887', 'article-title': 'Phase 2 randomized study on chloroquine, hydroxychloroquine or ' 'ivermectin in hospitalized patients with severe manifestations of ' 'SARS-CoV-2 infection', 'volume': '115', 'author': 'Galan', 'year': '2021', 'journal-title': 'Pathog Glob Health'}, { 'key': 'R16-20230917', 'article-title': 'Efficacy and safety of ivermectin and hydroxychloroquine in patients ' 'with severe COVID-19. A randomized controlled trial', 'author': 'Gonzalez', 'year': '2021', 'journal-title': 'Preprint Medrxiv.'}, { 'key': 'R17-20230917', 'article-title': 'Controlled randomized clinical trial on using ivermectin with ' 'doxycycline for treating COVID-19 patients in Baghdad, Iraq', 'author': 'Hashim', 'year': '2020', 'journal-title': 'Preprint Medrxiv.'}, { 'key': 'R18-20230917', 'doi-asserted-by': 'crossref', 'first-page': '411', 'DOI': '10.1186/s12879-021-06104-9', 'article-title': 'Evaluation of the effectiveness and safety of adding ivermectin to ' 'treatment in severe COVID-19 patients', 'volume': '21', 'author': 'Okumus', 'year': '2021', 'journal-title': 'BMC Infect Dis'}, { 'key': 'R19-20230917', 'article-title': 'Ivermectin as an adjunct treatment for hospitalized adult COVID-19 ' 'patients: a randomized multi-center clinical trial', 'author': 'Niaee', 'year': '2020', 'journal-title': 'Preprint Res Square'}, { 'key': 'R20-20230917', 'article-title': 'Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a ' 'randomised, controlled, open-label, platform trial', 'author': 'Horby', 'year': '2021', 'journal-title': 'Preprint Medrxiv.'}, { 'key': 'R21-20230917', 'doi-asserted-by': 'crossref', 'first-page': '605', 'DOI': '10.1016/S0140-6736(21)00149-5', 'article-title': 'Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): ' 'a randomised, controlled, open-label, platform trial', 'volume': '397', 'year': '2021', 'journal-title': 'Lancet'}, { 'key': 'R22-20230917', 'doi-asserted-by': 'crossref', 'first-page': '2030', 'DOI': '10.1056/NEJMoa2022926', 'article-title': 'Effect of hydroxychloroquine in hospitalized patients with covid-19', 'volume': '383', 'author': 'Horby', 'year': '2020', 'journal-title': 'N Engl J Med.'}, { 'key': 'R23-20230917', 'first-page': '55', 'article-title': 'Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a ' 'randomised, controlled, open-label, platform trial', 'volume': '2021', 'author': 'Horby', 'year': '2021', 'journal-title': 'Preprint Medrxiv.'}, { 'key': 'R24-20230917', 'doi-asserted-by': 'crossref', 'first-page': '2049', 'DOI': '10.1016/S0140-6736(21)00897-7', 'article-title': 'Convalescent plasma in patients admitted to hospital with COVID-19 ' '(RECOVERY): a randomised controlled, open-label, platform trial', 'volume': '397', 'year': '2021', 'journal-title': 'Lancet'}, { 'key': 'R25-20230917', 'doi-asserted-by': 'crossref', 'first-page': '1345', 'DOI': '10.1016/S0140-6736(20)32013-4', 'article-title': 'Lopinavir-ritonavir in patients admitted to hospital with COVID-19 ' '(RECOVERY): a randomised, controlled, open-label, platform trial', 'volume': '396', 'year': '2020', 'journal-title': 'Lancet'}], 'container-title': 'American Journal of Therapeutics', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://journals.lww.com/10.1097/MJT.0000000000001441', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2023, 9, 17]], 'date-time': '2023-09-17T04:19:01Z', 'timestamp': 1694924341000}, 'score': 1, 'resource': {'primary': {'URL': 'https://journals.lww.com/10.1097/MJT.0000000000001441'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2021, 8, 6]]}, 'references-count': 24, 'journal-issue': {'issue': '5', 'published-online': {'date-parts': [[2021]]}}, 'URL': 'http://dx.doi.org/10.1097/MJT.0000000000001441', 'relation': {}, 'ISSN': ['1075-2765'], 'subject': [], 'published': {'date-parts': [[2021, 8, 6]]}}